Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1996 to 2010 of 8999 results

  1. BioTime's Premvia HyStem hydrogel for the management of a wide range of wounds

    Topic prioritisation

  2. MT660 CerebAir for monitoring continuous, real-time EEG

    Topic prioritisation

  3. Dimethyl fumarate for treating relapsing-remitting multiple sclerosis in people aged 13 to 17 [TSID11778]

    Topic prioritisation

  4. Glatiramer acetate depot for multiple sclerosis [TSID10620]

    Topic prioritisation

  5. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

    Topic prioritisation

  6. Zavegepant for treating acute migraine [TSID11998]

    Awaiting development Reference number: GID-TA11527 Expected publication date: TBC

  7. Cenobamate for adjunctive treatment of primary generalised tonic-clonic seizures in epilepsy [TSID10214]

    Awaiting development Reference number: GID-TA11069 Expected publication date: TBC

  8. Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]

    Topic prioritisation

  9. STS101 for treating acute migraine [TSID11782]

    Topic prioritisation

  10. Dronabinol for treating muscle spasticity in multiple sclerosis after 2 treatments [TSID10638]

    Topic prioritisation

  11. Artificial intelligence (AI) technologies to aid contouring for radiotherapy treatment planning: early value assessment

    Awaiting development Reference number: GID-HTG10389 Expected publication date: TBC

  12. Technologies to improve detection of endometrial cancer

    Awaiting development Reference number: GID-HTG10173 Expected publication date: TBC

  13. Full Endoscopic Spine Surgery

    Topic prioritisation

  14. Eptinezumab for preventing cluster headache attacks TSID 12087

    Topic prioritisation